Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study

BACKGROUND: In the American Joint Committee on Cancer (AJCC) classification, acral lentiginous melanoma (ALM) histotype ALM is not included as an independent prognostic factor; in small series its negative prognostic impact on disease-free survival (DFS) and overall survival (OS) has been linked to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandalà, M., Rutkowski, P., Galli, F., Patuzzo, R., De Giorgi, V., Rulli, E., Gianatti, A., Valeri, B., Merelli, B., Szumera-Ciećkiewicz, A., Massi, D., Maurichi, A., Teterycz, P., Santinami, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271470/
https://www.ncbi.nlm.nih.gov/pubmed/35421840
http://dx.doi.org/10.1016/j.esmoop.2022.100469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271470/
https://www.ncbi.nlm.nih.gov/pubmed/35421840
http://dx.doi.org/10.1016/j.esmoop.2022.100469

Ejemplares similares